PET Imaging as a Tool for Assessing COVID-19 Brain Changes

Igor Camargo Fontana, Salvatore Bongarzone, Antony Gee, Diogo O Souza, Eduardo R Zimmer

Research output: Contribution to journalShort surveypeer-review

17 Citations (Scopus)


A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
Original languageEnglish
Pages (from-to)935-938
Number of pages4
JournalTrends in Neurosciences
Issue number12
Publication statusPublished - 22 Oct 2020


  • PET radiotracers
  • SARS-CoV-2
  • neurological manifestations


Dive into the research topics of 'PET Imaging as a Tool for Assessing COVID-19 Brain Changes'. Together they form a unique fingerprint.

Cite this